Qubit Pharmaceuticals
PrivateLast Round
Grant
Jul 10, 2024
Total Funding Raised
$41.91M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Qubit Pharmaceuticals is a biotechnology company that develops a drug discovery platform using quantum physics, AI, and high-performance computing to create novel treatments for oncology and inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Qubit Pharmaceuticals Comparables
Compare Qubit Pharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Aqemia | 89% | |
| Genesis Molecular AI | 84% | |
| BEIT | 81% |
Qubit Pharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jul 10, 2024 | ||||
| Grant | Nov 16, 2023 | ||||
| Grant | Sep 26, 2023 | ||||
| Grant | Jun 16, 2022 | ||||
| Seed | Jun 10, 2022 | ||||
Grant | Jun 16, 2021 |
Key People
Founding team and executive leadership
Qubit Pharmaceuticals Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
| Wellcome Leap | Grant |
| Secrétariat Général pour l'Investissement | Grant |
| Quantonation | Seed, Pre Seed |
| Omnes Capital | Seed |
| XAnge | Seed |
| Bpifrance | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors increased 118% MoM.
- Oct 1, 2025
Grew to 7 programs in oncology, immunology, and antivirals.
Qubit Pharmaceuticals Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Qubit Pharmaceuticals's valuation, stock price, and market status.
Is Qubit Pharmaceuticals a public or private company?
Qubit Pharmaceuticals is a private company.
What is the current stock price of Qubit Pharmaceuticals?
Qubit Pharmaceuticals is a private company, so its shares have no public market price. Caplight tracks Qubit Pharmaceuticals's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Qubit Pharmaceuticals worth (valuation)?
Valuation information for Qubit Pharmaceuticals is not publicly available.
Can I buy Qubit Pharmaceuticals stock?
Qubit Pharmaceuticals shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Qubit Pharmaceuticals's last funding round?
Qubit Pharmaceuticals's most recent funding round was Grant on July 10, 2024.
Who are the main investors in Qubit Pharmaceuticals?
Key investors in Qubit Pharmaceuticals include Quantonation, XAnge.
Will Qubit Pharmaceuticals IPO soon?
No public IPO plans have been announced for Qubit Pharmaceuticals.
How can I track Qubit Pharmaceuticals secondary market activity?
Caplight tracks bids, offers, and trades in Qubit Pharmaceuticals's shares on secondary markets.